Compare NNNN & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | NPKI |
|---|---|---|
| Founded | 2021 | 1932 |
| Country | Germany | United States |
| Employees | 27 | 510 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | NNNN | NPKI |
|---|---|---|
| Price | $31.82 | $15.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.17 |
| AVG Volume (30 Days) | 14.1K | ★ 805.9K |
| Earning Date | 04-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.39 |
| Revenue Next Year | N/A | $11.70 |
| P/E Ratio | $446.57 | ★ $38.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.58 | $7.92 |
| 52 Week High | $55.65 | $16.50 |
| Indicator | NNNN | NPKI |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 57.73 |
| Support Level | $26.31 | $14.09 |
| Resistance Level | $44.06 | $16.50 |
| Average True Range (ATR) | 2.86 | 0.56 |
| MACD | 0.59 | -0.00 |
| Stochastic Oscillator | 70.78 | 86.79 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.